CD34 and carcinoma: Strong EpCAM expression was restricted to the two carcinomas, while hemangiopericytoma cells were the only displaying CD34+hi expression; both groups of tumors systematically lacked CD45, B- and T-cell markers (Table 2; Figures 1 and 2).